OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dashboard-Driven Accelerated Infliximab Induction Dosing Increases Infliximab Durability and Reduces Immunogenicity
Marla C. Dubinsky, Michelle Mendiolaza, Becky L. Phan, et al.
Inflammatory Bowel Diseases (2022) Vol. 28, Iss. 9, pp. 1375-1385
Closed Access | Times Cited: 57
Marla C. Dubinsky, Michelle Mendiolaza, Becky L. Phan, et al.
Inflammatory Bowel Diseases (2022) Vol. 28, Iss. 9, pp. 1375-1385
Closed Access | Times Cited: 57
Showing 51-75 of 57 citing articles:
Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review
A Démaris, Ella S. K. Widigson, J F K F Ilvemark, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2095-2095
Open Access | Times Cited: 3
A Démaris, Ella S. K. Widigson, J F K F Ilvemark, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2095-2095
Open Access | Times Cited: 3
Infliximab in paediatric inflammatory bowel disease: External evaluation of population pharmacokinetic models
Omnia Salah Heikal, Patrick F. van Rheenen, Daan J. Touw, et al.
British Journal of Clinical Pharmacology (2024) Vol. 90, Iss. 9, pp. 2200-2214
Open Access
Omnia Salah Heikal, Patrick F. van Rheenen, Daan J. Touw, et al.
British Journal of Clinical Pharmacology (2024) Vol. 90, Iss. 9, pp. 2200-2214
Open Access
Editorial: achievements and unresolved questions in improving the pharmacokinetics of vedolizumab in adolescents with inflammatory bowel disease
S Vuijk, Lissy de Ridder
Alimentary Pharmacology & Therapeutics (2023) Vol. 57, Iss. 5, pp. 565-566
Open Access | Times Cited: 1
S Vuijk, Lissy de Ridder
Alimentary Pharmacology & Therapeutics (2023) Vol. 57, Iss. 5, pp. 565-566
Open Access | Times Cited: 1
Salvage Therapy in Acute Severe Ulcerative Colitis: Current Practice and a Look to the Future
Natalie Tamir‐Degabli, Nitsan Maharshak, Nathaniel A. Cohen
The Turkish Journal of Gastroenterology (2023) Vol. 34, Iss. 6, pp. 576-583
Open Access | Times Cited: 1
Natalie Tamir‐Degabli, Nitsan Maharshak, Nathaniel A. Cohen
The Turkish Journal of Gastroenterology (2023) Vol. 34, Iss. 6, pp. 576-583
Open Access | Times Cited: 1
Application of a Precision‐Dosing Model to a Real‐World Cohort of Patients on Infliximab Maintenance Therapy: Drug Usage and Cost Analysis
Anke L. Nguyen, Peter R. Gibson, Richard N. Upton, et al.
The Journal of Clinical Pharmacology (2023) Vol. 64, Iss. 4, pp. 399-409
Open Access | Times Cited: 1
Anke L. Nguyen, Peter R. Gibson, Richard N. Upton, et al.
The Journal of Clinical Pharmacology (2023) Vol. 64, Iss. 4, pp. 399-409
Open Access | Times Cited: 1
Precision medicine in inflammatory bowel disease: Individualizing the use of biologics and small molecule therapies
Eric Cheah, James Guoxian Huang
World Journal of Gastroenterology (2023) Vol. 29, Iss. 10, pp. 1395-1406
Closed Access
Eric Cheah, James Guoxian Huang
World Journal of Gastroenterology (2023) Vol. 29, Iss. 10, pp. 1395-1406
Closed Access
Demo: Cohort Visualization and Analysis of Patients with Inflammatory Bowel Disease
David Sessler, Salmah Ahmad, Jörn Kohlhammer
(2023), pp. 41-43
Closed Access
David Sessler, Salmah Ahmad, Jörn Kohlhammer
(2023), pp. 41-43
Closed Access
Therapeutic Drug Monitoring in Practice for Inflammatory Bowel Disease
Bryant Megna, Byron P. Vaughn
Current Gastroenterology Reports (2022) Vol. 24, Iss. 12, pp. 191-200
Closed Access
Bryant Megna, Byron P. Vaughn
Current Gastroenterology Reports (2022) Vol. 24, Iss. 12, pp. 191-200
Closed Access
